Dr. Ashish Chawla M.D.

Recommended Articles

• What is the Difference Between IBS and IBD?

  Irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD) both chronic conditions that can trigger similar symptoms, including abdominal pain and urgency to make a bowel movement. In the United States, IBS is extremely common, affecting around 25 to 45 million Americans. IBD is also...

• Creating Low-Gluten Bread Made Possible with Gene-Editing Technique

  Gluten-free bread is a type of bread that doesn't have any wheat, barley and rye, and instead has a combination of starches like potato flour, cornstarch and rice flour. As there are people who experience adverse reactions whenever they consume food that contains gluten, gluten-free bread is...

• IBD Severity in Children Can Be Predicted by Genetic Testing

  The good news for children suffering from IBD and their parents is that a group of Norwegian research scientists has had a recent breakthrough in determining a new test to both diagnose and categorize IBD through the profiling of the bacterial composition of the large bowel.Inflammatory bowel...

• Tips On Recovering From Open Hernia Repair

  After surgery, the first thing everyone would like to ask the doctor is about recovery. Undoubtedly, no one wants to stay bedridden for very long and everyone wants to restart their normal activities as soon as possible. While the recovery time for open hernia repair varies from person to person,...

• Gastroenteritis in Children: Signs of Dehydration

  Gastroenteritis is an intestinal infection that is caused by poorly prepared foods, contaminated water, etc. It can cause diarrhea, nausea, headache, and vomiting.What causes it?Gastro is caused by viruses. They include:• Rotavirus• AdenovirusHow is the gastroenteritis virus passed?Children can...

• New Treatment for Celiac Disease Using Nanoparticles Is Underway

  Recently, investigators have found a potential way to develop a treatment for celiac disease, which, according to Cour Pharmaceuticals focuses on the autoimmune disease, along with other inflammatory diseases. The treatment has been approved for clinical trials in August, 2017, and these trials have...